IL-4 can promote development of specific immune cell subtypes, such as macrophages, B cells, CD4+Th2 cells, and CD8+ T cells, which play a pivotal role in the tumor progression of inflammation-related cancers, including HCC (Capece et al., 2013). Here, CD8A is linked to cancer.